Dont layer with Vitamin C, AHAs, BHAs, or retinoids in the same routine
Fosgonimeton failed its Phase 2 ACT-AD trial in 2022 and its Phase 2/3 LIFT-AD trial in September 2024
Stackable, Non-Suppressive Recovery Enhancement Unlike corticosteroids, NSAIDs, or AAS, BPC-157 does not: Suppress natural hormone production Interfere with training adaptations Alter blood pressure or cholesterol Require PCT or hormonal therapy This makes it ideal for: Year-round recovery support Injury prevention cycles Off-cycle tissue maintenance Bridging between high-stress training blocks Ideal BPC-157 Cycle Protocols Unlike suppressive or hepatotoxic compounds, BPC-157 can be cycled safely for longer periods , especially when the goal is complete tissue remodeling or recovery from chronic injury
Key Takeaways NAD has been shown to support healthy aging and longevity
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10), extended with a C-terminal Pro-Gly-Pro tripeptide to improve metabolic stability